Zhu, Yajing http://orcid.org/0009-0008-4953-6195
Zerdes, Ioannis
Matikas, Alexios
Cruz, Ivette Raices
Bergqvist, Mattias
Elinder, Ellinor
Bosch, Ana
Lindman, Henrik
Einbeigi, Zakaria
Andersson, Anne
Carlsson, Lena
Dreifaldt, Ann Charlotte
Isaksson-Friman, Erika
Hellstrom, Mats
Johansson, Hemming
Wang, Kang
Bergh, Jonas C. S.
Hatschek, Thomas
Foukakis, Theodoros
Clinical trials referenced in this document:
Documents that mention this clinical trial
The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial
https://doi.org/10.1007/s10549-023-07200-x
Funding for this research was provided by:
Cancerfonden (21 0277 JCIA 01)
Karolinska Institute
Article History
Received: 24 July 2023
Accepted: 26 November 2023
First Online: 4 January 2024
Declarations
:
: Yajing Zhu, Ioannis Zerdes, Ivette Raices Cruz, Ellinor Elinder, Henrik Lindman, Zakaria Einbeigi, Ann Charlotte Dreifaldt, Anne Andersson, Lena Carlsson, Erika Isaksson-Friman, Mats Hellstrom, Hemming Johansson and Kang Wang have no conflicts of interest to disclose; Jonas Bergh: research funding from Merck paid to Karolinska Institutet and from Amgen, Bayer, Pfizer, Roche and Sanofi-Aventis paid to Karolinska University Hospital. No personal payments. Payment from UpToDate for a chapter in breast cancer prediction paid to Asklepios Medicine HB. Theodoros Foukakis: institutional research grants from Roche, Astra Zeneca, Novartis, Veracyte and Pfizer, institutional fees from Roche, Pfizer, Gilead Sciences and Astra Zeneca and personal fees from Affibody, Novartis, Pfizer, Exact Sciences, Veracyte and UpToDate. Alexios Matikas: consultancy to Veracyte (no financial or other compensation) and Roche (no financial or other compensation). Ana Bosch: Institutional honoraria from Pfizer, Roche and Lilly for consultation and lectures. Participated in Advisory Board meetings for Pfizer and Novartis. Co-founder and chair of the board for SACRA therapeutics. Mattias Bergqvist is an employee of Biovica and holds stock in the company.